-
Qian Geng1,2,Ruiting Xian1,Yinjue Yu1,Fengsheng Chen3,Rong Li1(Department of Oncology;Cancer Center;Integrated Hospital of Traditional Chinese Medicine).SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer[J].癌症生物学与医学(英文版),2022,第4期
-
Yu Mei1,Tienan Feng2,Min Yan1,Zhenggang Zhu1,Zhenglun Zhu1(Department of General Surgery;Clinical Research Institute).Is adjuvant chemotherapy necessary for early gastric cancer?[J].癌症生物学与医学(英文版),2022,第4期
-
Xiaodong Zhang,Yufei Wang2,Guang Yang(Department of Gastrointestinal Cancer Biology;Department of Cancer Research).Research progress in hepatitis B virus covalently closed circular DNA[J].癌症生物学与医学(英文版),2022,第4期
-
Hui Yang1,Yinuo Wang1,Peng Wang1,Ning Zhang1,Pengyuan Wang1,2(Translational Cancer Research Center Peking University First Hospital;Division of General SurgeryPeking University First Hospital).Tumor organoids for cancer research and personalized medicine[J].Cancer Biology & Medicine,2022,第3期
-
Hanfei Guo, Lei Qian, Jiuwei Cui(Cancer Center,the First Hospital of Jilin University,Changchun 130021,China).Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome[J].Cancer Biology & Medicine,2022,第3期
-
Xiaowei Ji1,2,Jing Wang2,Zhuoying Li1,2,Qiuming Shen1,2,Jiayi Tuo1,2,Jinghao Bi1,2,Yuting Tan2,Honglan Li2,Yongbing Xiang1,2(State Key Laboratory of Oncogene and Related Genes & Department of Epidemiology Shanghai Cancer Institute Renji Hospital Shanghai Jiao Tong University School of Medicine;School of Public Health Shanghai Jiao Tong University School of Medicine).Dietary fat intake and liver cancer risk: A prospective cohort study in Chinese women[J].Cancer Biology & Medicine,2022,第3期
-
Liwei An1,2,Ruixian Yu1,Yi Han2,Zhaocai Zhou1(State Key Laboratory of Genetic Engineering Zhongshan Hospital School of Life Sciences Fudan University;Department of Medical Ultrasound Shanghai Tenth People’s Hospital Tongji University School of MedicineShanghai Engineering Research Centre of Ultrasound Diagnosis and Treatment).Decoding the intercellular communication network during tumorigenesis[J].Cancer Biology & Medicine,2022,第3期
-
Hua Ye1,Tianqi Chen2,Zhancheng Zeng2,Bo He3,Qianqian Yang2,Qi Pan2,Yueqin Chen2,Wentao Wang2(Department of Hepatobiliary Sun Yat-sen Memorial Hospital Sun Yat-sen University;Key Laboratory of Gene Engineering of the Ministry of Education School of Life Sciences Sun Yat-sen University;Department of Anesthesiology Sun Yat-sen Memorial Hospital Sun Yat-sen University).The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma[J].Cancer Biology & Medicine,2022,第3期
-
Kaiting Wang1,Xinyao Qiu2,Yan Zhao1,Hongyang Wang3,4,Lei Chen4(School of Life Sciences Fudan University;Fudan University Shanghai Cancer Center Department of Oncology Shanghai Medical College Fudan University;Institute of Metabolism & Integrative Biology (IMIB) Fudan University;The International Cooperation Laboratory on Signal TransductionEastern Hepatobiliary Surgery Hospital Second Military Medical University).The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma[J].Cancer Biology & Medicine,2022,第3期
-
Ming Bai;Meng Wang;Ting Deng;Yuxian Bai2;Kai Zang3;Zhanhui Miao4;Wenlin Gai5;Liangzhi Xie5,6,7;Yi Ba(Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy;Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital;Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University;Oncology Department,The First Affiliated Hospital of Xinxiang Medical University;Sinocelltech Ltd.;Beijing Engineering Research Center of Protein and Antibody;Cell Culture Engineering Center,Chinese Academy of Medical Sciences & Peking Union Medical College).Safety and efficacy of anti-EGFR monoclonal antibody(SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma[J].Cancer Biology & Medicine,2022,第3期
-
Yingcheng Wu1,Tiancheng Zhang1,Xiaoming Zhang2,Qiang Gao1,3,4(Department of Liver Surgery and Transplantation Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education) Liver Cancer Institute Zhongshan Hospital Fudan University;The Center for MicrobesDevelopment and Health Key Laboratory of Molecular Virology and Immunology Institute Pasteur of Shanghai Chinese Academy of Sciences;Key Laboratory of Medical Epigenetics and Metabolism Institutes of Biomedical Sciences Fudan University;State Key Laboratory of Genetic Engineering Fudan University).Decoding the complexity of metastasis[J].Cancer Biology & Medicine,2022,第3期
-
Nahid Arghiani1,2,Khalid Shah1,2,3(Center for Stem Cell and Translational Immunotherapy (CSTI) Harvard Medical School Boston MA 02115;Department of Neurosurgery Brigham and Women’s Hospital Harvard Medical School Boston MA 02115;Harvard Stem Cell Institute Harvard University Cambridge MA 02138).Modulating microRNAs in cancer: next-generation therapies[J].Cancer Biology & Medicine,2022,第3期
-
Xixi Li, Xinya Gao, Nu Zhang(Department of Neurosurgery,Sun Yat-sen University,The First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China).Perspective on novel proteins encoded by circular RNAs in glioblastoma[J].Cancer Biology & Medicine,2022,第3期
-
Wei Liu1,2,Yongping Cui3,Wen Liu4,Zhihua Liu5,Liyan Xu2,Enmin Li2(College of Science Heilongjiang Institute of Technology;Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology the Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area Shantou University Medical College;Department of Pathology Key Laboratory of Cellular Physiology (Shanxi Medical University) Ministry of Education;Fujian Provincial Key Laboratory of Innovative Drug Target Research School of Pharmaceutical Sciences Xiamen University;State Key Lab of Molecular Oncology National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College).Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma[J].Cancer Biology & Medicine,2022,第3期
-
Sha Li1,2,Jinyi Liu1,2,Xiangjin Zheng1,2,Liwen Ren1,2,Yihui Yang1,2,Wan Li1,2,Weiqi Fu1,2,Jinhua Wang1,2,Guanhua Du1,2(The State Key Laboratory of Bioactive Substance and Function of Natural Medicines;Key Laboratory of Drug Target Research and Drug ScreenInstitute of Materia MedicaChinese Academy of Medical Science and Peking Union Medical College).Tumorigenic bacteria in colorectal cancer: mechanisms and treatments[J].Cancer Biology & Medicine,2022,第2期
-
Jingyu Ge1,2,Wenjia Zuo1,2,Yiyu Chen1,2,Zhiming Shao1,2,Keda Yu1,2(Department of Breast SurgeryFudan University Shanghai Cancer Center;Shanghai Medical CollegeFudan University).The advance of adjuvant treatment for triple-negative breast cancer[J].Cancer Biology & Medicine,2022,第2期
-
Yufei Jiang1,2,3,Huiyun Yuan2,3,Zhuoying Li1,2,3,Xiaowei Ji1,2,3,Qiuming Shen1,2,3,Jiayi Tuo1,2,3,Jinghao Bi1,2,3,Honglan Li1,2,Yongbing Xiang1,2,3(State Key Laboratory of Oncogene and Related Genes & Department of EpidemiologyShanghai Cancer InstituteRenji HospitalShanghai Jiao Tong University School of Medicine;Renji HospitalShanghai Jiao Tong University School of Medicine;School of Public HealthShanghai Jiao Tong University School of Medicine).Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data[J].Cancer Biology & Medicine,2022,第2期
-
Xiaodong Zhang,Chunyu Hou,Guang Yang(Department of Gastrointestinal Cancer Biology,Liver Cancer Center,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China).Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors[J].Cancer Biology & Medicine,2022,第2期
-
Qian Hao1,2,Xiang Zhou1,2,3,4(Fudan University Shanghai Cancer Center and Institutes of Biomedical SciencesFudan University;Department of OncologyShanghai Medical CollegeFudan University;Key Laboratory of Breast Cancer in ShanghaiFudan University Shanghai Cancer CenterFudan University;Shanghai Key Laboratory of Medical EpigeneticsInternational Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology)Institutes of Biomedical SciencesFudan University).The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy[J].Cancer Biology & Medicine,2022,第2期
-
Fenfen Fu1,Dongjie Zhang1,Li Hu2,Senthil Sundaram3,Dingge Ying3,Ying Zhang4,Shuna Fu4,Juan Zhang2,Lu Yao2,Ye Xu2,Yuntao Xie1,2(Department of Breast Surgery, Peking University International Hospital;Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Familial & Hereditary Cancer Center, Peking University Cancer Hospital & Institute;Prenetics Limited;Beijing CircleDNA Gene Technology Co., Ltd.).Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women[J].Cancer Biology & Medicine,2022,第2期
-
Xinyi Zhou1,Qian Xiao1,Dongliang Fu1,Haochen Zhang2,Yang Tang1,Jinjie He1,Yeting Hu1,Xiangxing Kong1,Fei Teng3,Xiangrui Liu4,Ying Yuan2,Kefeng Ding1,5(Department of Colorectal Surgery and Oncology;Department of Medical OncologyKey Laboratory of Cancer Prevention and InterventionMinistry of Educationthe Second Affiliated Hospital of Zhejiang University School of Medicine;Hangzhou Oncocare Co Ltd;Department of PharmacologyZhejiang University School of Medicine;Cancer CenterZhejiang University).Efficacy of rigosertib,a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer[J].Cancer Biology & Medicine,2022,第2期
-
Lin Qian1,2,Fan Zhang1,2,Miao Yin1,2,Qunying Lei1,2,3,4(Fudan University Shanghai Cancer Center & Institutes of Biomedical SciencesCancer InstitutesKey Laboratory of Breast Cancer in ShanghaiShanghai Key Laboratory of Radiation OncologyShanghai Key Laboratory of Medical EpigeneticsShanghai Medical CollegeFudan University;Department of OncologyShanghai Medical CollegeFudan University;State Key Laboratory of Medical NeurobiologyFudan University;Lead Contact).Cancer metabolism and dietary interventions[J].Cancer Biology & Medicine,2022,第2期
-
Poorni M.Manohar1,2,Nancy E.Davidson1,2(University of Washington/Seattle Cancer Care AllianceSeattle 98109WA;Fred Hutchinson Cancer Research CenterSeattle 98109WA).Updates in endocrine therapy for metastatic breast cancer[J].Cancer Biology & Medicine,2022,第2期
-
Yu Yu1,Minzhen Tao2,Libin Xu3,Lei Cao4,Baoyu Le5,Na An5,Jilin Dong5,Yajie Xu5,Baoxing Yang5,Wei Li5,Bing Liu5,Qiong Wu6,Yinying Lu7,Zhen Xie2,Xiaohua Lian1(Department of Cell BiologyBasic Medical CollegeArmy Medical University (Third Military Medical University);MOE Key Laboratory of Bioinformatics and Bioinformatics DivisionCenter for Synthetic and System BiologyDepartment of AutomationBeijing National Research Center for Information Science and TechnologyTsinghua University;National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College;Department of Thoracic SurgeryPeking Union Medical College HospitalChinese Academy of Medical Sciences;Beijing Syngentech Co.Ltd;School of Life SciencesTsinghua University;The Comprehensive Liver Cancer CenterThe 5th Medical Center of PLA General Hospital).Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells[J].Cancer Biology & Medicine,2022,第2期
-
Yuchen Guo,Yangyang Zhou,Wenxin Qin(State Key Laboratory of Oncogenes and Related GenesShanghai Cancer InstituteRenji HospitalShanghai Jiao Tong University School of Medicine).A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer[J].Cancer Biology & Medicine,2022,第2期
-
Mengyuan Yang,Yingxin Zhao,Yuwei Ding,Juan Wang,Yinuo Tan,Dong Xu,Ying Yuan(Department of Medical OncologyKey Laboratory of Cancer Prevention and InterventionMinistry of EducationThe Second Affiliated HospitalZhejiang University School of Medicine;Cancer InstituteKey Laboratory of Cancer Prevention and InterventionMinistry of EducationThe Second Affiliated HospitalZhejiang University School of Medicine;Department of Colorectal Surgery and OncologyKey Laboratory of Cancer Prevention and InterventionMinistry of EducationThe Second Affiliated HospitalZhejiang University School of Medicine).Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis[J].Cancer Biology & Medicine,2022,第2期
-
Mengyuan Yang,Yingxin Zhao,Yuwei Ding,Juan Wang,Yinuo Tan,Dong Xu,Ying Yuan(Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,The Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou;The Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009).Erratum to A truncated protein product of the germline variant of the DU0X2 gene leads to adenomatous polyposis[J].癌症生物学与医学(英文版),2022,第2期
-
Yan Zeng1,Yutian Zou1,Guanfeng Gao1,Shaoquan Zheng1,Song Wu1,Xiaoming Xie1,Hailin Tang1(Sun Yat-sen University Cancer Center;State Key Laboratory of Oncology in South China;Collaborative Innovation Center for Cancer Medicine).The biogenesis,function and clinical significance of circular RNAs in breast cancer[J].Cancer Biology & Medicine,2022,第1期
-
Haixia Shan1,2,Bo Wang1,3,Xiaodong Zhang1,Hui Song1,Xi Li4,Yongxin Zou4,Baichun Jiang4,Huili Hu4,Hao Dou4,Changshun Shao4,Lifen Gao1,5,Chunhong Ma1,5,Xiaoyun Yang6,Xiaohong Liang1,5,Yaoqin Gong4(Key Laboratory for Experimental Teratology of the Ministry of EducationKey Laboratory of Infection and Immunity of Shandong Province and Department of ImmunologySchool of Basic Medical SciencesShandong University;Department of Laboratory DiagnosisCangzhou Combination of Traditional Chinese and Western Medicine Hospital of Hebei Province;Division of Gastroenterology and HepatologyRenji HospitalSchool of MedicineShanghai Jiao Tong UniversityShanghai Institute of Digestive Disease;Ministry of Education Key Laboratory of Experimental Teratology and Institute of Molecular Medicine and GeneticsSchool of Basic Medical SciencesShandong University;Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong;Department of GastroenterologyQilu HospitalShandong University).CUL4B facilitates HBV replication by promoting HBx stabilization[J].Cancer Biology & Medicine,2022,第1期
|